HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AB&B BIO-TECH-B

29.320

0.000

Volume:- -

Turnover:- -

Market Cap:11.52B

PE:-35.46

High:29.320

Open:29.320

Low:29.320

Close:29.320

52wk High:73.000

52wk Low:28.880

Shares:393.00M

HK Float Shares:296.36M

Volume Ratio:0.51

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.827

ROE:--

ROA:--

PB:297.56

PE(LYR):-35.46

PS:30.93

Loading ...

Overview Company News Filings

Hong Kong Stock Movement | AB&B BIO-TECH-B (02627) Surges Over 7%, Broad Potential Growth Space for Domestic Flu Vaccines

AB&B BIO-TECH-B (02627): Cheng Qianwen Resigns as Non-Executive Director

AB&B Bio-Tech Co. Ltd. JS Non-Executive Director and Board Secretary Resign

AB&B Bio-Tech Co. Ltd. JS Files Director List with HKEX

AB&B BIO-TECH-B (02627): Li Jianjun Elected as Independent Non-Executive Director

AB&B Bio-Tech Co. Ltd. JS Held Extraordinary General Meeting

AB&B BIO-TECH-B (02627) Initiates Phase III Clinical Trial for Freeze-Dried Human Rabies Vaccine (HDCV)

AB&B Bio-Tech Launches Phase III Trial of Lyophilized Human Rabies Vaccine

Ab&B Bio-Tech (2627) Releases Proxy Form for Second EGM in December 2025

Bulletin Express

AB&B BIO-TECH-B (02627) Nominates Li Jianjun as Independent Non-Executive Director Candidate

AB&B Bio-Tech Co. Ltd. JS Announces Date for Second Extraordinary General Meeting of 2025

Ab&B Bio-Tech (2627) Announces Independent Director Resignation and Nominates Successor

Bulletin Express

AB&B Bio-Tech Co. Ltd. JS Appoints New Independent Director and Reshuffles Board Committees

Breakthrough! AB&B BIO-TECH-B's Quadrivalent Influenza Subunit Vaccine "HuiErKangXin" Exported to Macau for the First Time

10th Zhitong Capital Market Annual Conference Honors Excellence with 25 Awards Unveiled

Ab&B Bio-Tech Co., Ltd. JS (02627) Provides Monthly Return for November 2025

Bulletin Express

Riding the Hong Kong Stock Rally: Bull Market Dawns in the East 2026 – 10th Zhitong Finance Capital Markets Annual Conference Invites You to a Capital Feast

Ab&B Bio-Tech (2627) Announces Commencement of Phase I Clinical Trials for Influenza Vaccines

Bulletin Express

AB&B BIO-TECH-B (02627) Initiates Phase I Clinical Trials for Quadrivalent and Trivalent Influenza Subunit Vaccines (Adjuvanted)

AB&B Bio-Tech Launches Phase I Trial for Adjuvanted Influenza Vaccines

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/02627/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02627","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02627\",,,,,undefined,":{"symbol":"02627","market":"HK","secType":"STK","nameCN":"AB&B BIO-TECH-B","latestPrice":29.32,"timestamp":1776388867154,"preClose":29.32,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":296361845,"shares":393000000,"eps":-0.8268295681518879,"marketStatus":"Halted","change":0,"latestTime":"04-17 09:21:07","open":29.32,"high":29.32,"low":29.32,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.7190772764329614,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1776648600000},"marketStatusCode":7,"adr":0,"listingDate":1754841600000,"exchange":"SEHK","adjPreClose":29.32,"openAndCloseTimeList":[[1776389400000,1776398400000],[1776402000000,1776412800000]],"volumeRatio":0.5100838100119135,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02627\",,,,,undefined,":{"symbol":"02627","floatShares":296361845,"roa":"--","roe":"--","lyrEps":-0.82683,"volumeRatio":0.5100838100119135,"shares":393000000,"dividePrice":0,"high":29.32,"amplitude":0,"preClose":29.32,"low":29.32,"week52Low":28.88,"pbRate":"297.56","psRate":"30.93","week52High":73,"institutionHeld":0,"latestPrice":29.32,"eps":-0.8268295681518879,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.7190772764329614,"open":29.32,"prevYearClose":40.24,"prevWeekClose":29.32,"prevMonthClose":29.32,"prevQuarterClose":29.32,"fiveDayClose":29.32,"twentyDayClose":38.6,"sixtyDayClose":46.92},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02627\",params:#limit:5,,,undefined,":[{"date":"2026-03-31","symbol":"02627","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774920600000,"name":null,"time":"","dateTimestamp":1774886400000,"actualEps":null},{"date":"2025-08-28","symbol":"02627","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756344600000,"name":null,"time":"","dateTimestamp":1756310400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02627\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02627\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02627\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02627","date":"2026-04-17","current":-40.774477,"percent":0.97619,"low":-109.844469,"twenty":-78.181043,"median":-65.711289,"eighty":-63.227242,"high":-18.07815,"avg":-67.792097,"sd":11.647747,"marketCap":11535737032},"quantilePoints":[{"date":"2025-08-08","current":-18.07815,"twenty":-18.07815,"median":-18.07815,"eighty":-18.07815,"marketCap":5586884920},{"date":"2025-08-15","current":-60.155426,"twenty":-60.155426,"median":-56.438909,"eighty":-42.414982,"marketCap":18562621868},{"date":"2025-08-22","current":-65.870069,"twenty":-65.897052,"median":-63.746879,"eighty":-55.654938,"marketCap":20262293900},{"date":"2025-08-29","current":-64.920623,"twenty":-66.830053,"median":-65.395346,"eighty":-57.22288,"marketCap":20065572600},{"date":"2025-09-05","current":-62.716917,"twenty":-66.416243,"median":-63.912829,"eighty":-60.155426,"marketCap":19365244772},{"date":"2025-09-12","current":-62.655098,"twenty":-66.251138,"median":-63.08644,"eighty":-59.27469,"marketCap":19380982476},{"date":"2025-09-19","current":-81.048551,"twenty":-68.315951,"median":-63.912829,"eighty":-59.882299,"marketCap":19888523430},{"date":"2025-09-26","current":-77.095946,"twenty":-77.153546,"median":-65.395346,"eighty":-60.155426,"marketCap":18869507096},{"date":"2025-10-03","current":-76.784092,"twenty":-77.86406,"median":-66.074095,"eighty":-61.128611,"marketCap":18838031688},{"date":"2025-10-10","current":-75.450727,"twenty":-78.338288,"median":-66.623148,"eighty":-61.710077,"marketCap":18483933348},{"date":"2025-10-17","current":-70.044793,"twenty":-77.841467,"median":-68.315951,"eighty":-62.332762,"marketCap":17146228508},{"date":"2025-10-24","current":-70.694139,"twenty":-77.356453,"median":-69.86748,"eighty":-62.632094,"marketCap":17311474400},{"date":"2025-10-31","current":-64.652972,"twenty":-77.130506,"median":-68.586563,"eighty":-62.679826,"marketCap":15855736780},{"date":"2025-11-07","current":-65.014442,"twenty":-77.0495,"median":-67.012733,"eighty":-63.012535,"marketCap":15934425300},{"date":"2025-11-14","current":-69.152784,"twenty":-76.901535,"median":-66.692171,"eighty":-63.572329,"marketCap":16996720320},{"date":"2025-11-21","current":-64.47659,"twenty":-76.671062,"median":-66.251138,"eighty":-63.813259,"marketCap":15839999076},{"date":"2025-11-28","current":-66.221916,"twenty":-76.081201,"median":-65.883561,"eighty":-63.948664,"marketCap":16327867900},{"date":"2025-12-05","current":-64.387851,"twenty":-75.140133,"median":-65.711289,"eighty":-64.052768,"marketCap":15902949892},{"date":"2025-12-12","current":-65.09579,"twenty":-74.230454,"median":-65.51992,"eighty":-64.060512,"marketCap":16107540044},{"date":"2025-12-19","current":-64.75238,"twenty":-73.314016,"median":-65.09579,"eighty":-64.128623,"marketCap":16060326932},{"date":"2025-12-24","current":-63.88714,"twenty":-72.937878,"median":-65.019631,"eighty":-64.128296,"marketCap":15895081040},{"date":"2026-01-02","current":-63.38466,"twenty":-72.68164,"median":-64.955716,"eighty":-63.907691,"marketCap":15832130224},{"date":"2026-01-09","current":-64.42138,"twenty":-72.421694,"median":-64.920623,"eighty":-63.984499,"marketCap":16131146600},{"date":"2026-01-16","current":-79.012958,"twenty":-72.68164,"median":-65.002626,"eighty":-63.984499,"marketCap":19849179170},{"date":"2026-01-23","current":-80.264585,"twenty":-74.684429,"median":-65.09579,"eighty":-64.012742,"marketCap":20144261120},{"date":"2026-01-30","current":-75.685884,"twenty":-76.499114,"median":-65.441715,"eighty":-64.034272,"marketCap":19081966100},{"date":"2026-02-06","current":-72.661412,"twenty":-75.84841,"median":-65.678772,"eighty":-64.110439,"marketCap":18365900568},{"date":"2026-02-13","current":-79.706332,"twenty":-76.558032,"median":-65.817553,"eighty":-64.12895,"marketCap":20262293900},{"date":"2026-02-20","current":-82.611175,"twenty":-76.790716,"median":-65.857422,"eighty":-64.132361,"marketCap":20970490580},{"date":"2026-02-27","current":-82.941496,"twenty":-77.55936,"median":-66.221916,"eighty":-64.146544,"marketCap":21285244660},{"date":"2026-03-06","current":-81.374491,"twenty":-78.249638,"median":-66.33369,"eighty":-64.163416,"marketCap":20714752890},{"date":"2026-03-13","current":-88.155391,"twenty":-78.824484,"median":-66.830053,"eighty":-64.221195,"marketCap":22544260980},{"date":"2026-03-20","current":-60.352659,"twenty":-78.705126,"median":-66.485266,"eighty":-64.132361,"marketCap":15375736808},{"date":"2026-03-27","current":-47.779776,"twenty":-78.691316,"median":-66.244034,"eighty":-64.004997,"marketCap":12141638636},{"date":"2026-04-02","current":-45.178314,"twenty":-78.677046,"median":-65.897052,"eighty":-63.746879,"marketCap":11535737032},{"date":"2026-04-10","current":-44.832534,"twenty":-78.441179,"median":-65.857422,"eighty":-63.430885,"marketCap":11535737032},{"date":"2026-04-17","current":-44.813717,"twenty":-78.181043,"median":-65.711289,"eighty":-63.227242,"marketCap":11535737032}],"updateTime":1776494311104},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02627\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1199612199","title":"Hong Kong Stock Movement | AB&B BIO-TECH-B (02627) Surges Over 7%, Broad Potential Growth Space for Domestic Flu Vaccines","url":"https://stock-news.laohu8.com/highlight/detail?id=1199612199","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199612199?lang=en_us&edition=fundamental","pubTime":"2026-01-15 14:19","pubTimestamp":1768457943,"startTime":"0","endTime":"0","summary":"AB&B BIO-TECH-B (02627) rose over 7%. As of the time of writing, the stock was up 7.54%, trading at HKD 46.5, with a turnover of HKD 18.84 million. On the news front, the National Health Commission...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02627"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161376748","title":"AB&B BIO-TECH-B (02627): Cheng Qianwen Resigns as Non-Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=1161376748","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161376748?lang=en_us&edition=fundamental","pubTime":"2026-01-12 17:18","pubTimestamp":1768209495,"startTime":"0","endTime":"0","summary":"AB&B BIO-TECH-B (02627) announced that Mr. Cheng Qianwen has tendered his resignation from his positions as a Non-Executive Director of the company and a member of the Board Audit Committee. His...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02627","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602590978","title":"AB&B Bio-Tech Co. Ltd. JS Non-Executive Director and Board Secretary Resign","url":"https://stock-news.laohu8.com/highlight/detail?id=2602590978","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602590978?lang=en_us&edition=fundamental","pubTime":"2026-01-12 17:11","pubTimestamp":1768209118,"startTime":"0","endTime":"0","summary":"AB&B Bio-Tech Co. Ltd. JS announced the resignation of Mr. Cheng Qianwen as non-executive director and member of the Audit Committee, with his resignation taking effect upon the election of a new non-executive director. Additionally, Ms. Zhang Xiaohua has resigned as board secretary and joint company secretary, while Ms. Lin Sio Ngo will continue to serve as company secretary.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AB&B Bio-Tech Co. Ltd. JS published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on January 12, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL5p1bg1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02627"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593491851","title":"AB&B Bio-Tech Co. Ltd. JS Files Director List with HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2593491851","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593491851?lang=en_us&edition=fundamental","pubTime":"2025-12-23 18:35","pubTimestamp":1766486102,"startTime":"0","endTime":"0","summary":"AB&B Bio-Tech Co. Ltd. JS , a joint stock company established in the People’s Republic of China, has filed its updated list of directors and their roles to the Hong Kong Stock Exchange. The Board consists of Executive Directors Mr. An Youcai , Ms. Li Runxiang, and Mr. He Yiming; Non-executive Directors Mr. Cheng Qianwen, Mr. Yu Jianlin, and Mr. Du Mu; and Independent Non-executive Directors Mr. Li Xiangming, Mr. Li Jianjun, and Mr. Chen Chengbei. The company’s board committees are structured as follows: Mr. Li Jianjun chairs the Audit Committee with Mr. Cheng Qianwen and Mr. Li Xiangming as members. Mr. Chen Chengbei chairs the Remuneration and Appraisal Committee, with Ms. Li Runxiang and Mr. Li Jianjun as members. Mr. Li Xiangming chairs the Nomination Committee, with Ms. Li Runxiang and Mr. Chen Chengbei as members. The Strategy Committee is chaired by Mr. An Youcai, with Mr. Cheng Qianwen and Mr. Li Xiangming as members.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nNDL4Z0RHr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02627"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191846851","title":"AB&B BIO-TECH-B (02627): Li Jianjun Elected as Independent Non-Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=1191846851","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191846851?lang=en_us&edition=fundamental","pubTime":"2025-12-23 18:34","pubTimestamp":1766486064,"startTime":"0","endTime":"0","summary":"AB&B BIO-TECH-B (02627) announced that the proposed resolution to appoint Mr. Li Jianjun as an independent non-executive director of the company was formally approved at an extraordinary general...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02627"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593549977","title":"AB&B Bio-Tech Co. Ltd. JS Held Extraordinary General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2593549977","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593549977?lang=en_us&edition=fundamental","pubTime":"2025-12-23 18:30","pubTimestamp":1766485810,"startTime":"0","endTime":"0","summary":"AB&B Bio-Tech Co. Ltd. JS held its second extraordinary general meeting on December 23, 2025. At the meeting, the appointment of Mr. Li Jianjun as an independent non-executive director was approved. Changes to the board committees were also approved, including the appointment of Mr. Li as chairperson of the Audit Committee and member of the Remuneration and Appraisal Committee, the appointment of Ms. Li Runxiang and Mr. Chen Chengbei as members of the Nomination Committee, and the cessation of Mr. Yu Jianlin as a member of the Nomination Committee.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AB&B Bio-Tech Co. Ltd. JS published the original content used to generate this news brief via IIS, the Issuer Information Service operated by t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nNDL8kZSJJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02627","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148973954","title":"AB&B BIO-TECH-B (02627) Initiates Phase III Clinical Trial for Freeze-Dried Human Rabies Vaccine (HDCV)","url":"https://stock-news.laohu8.com/highlight/detail?id=1148973954","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148973954?lang=en_us&edition=fundamental","pubTime":"2025-12-08 17:18","pubTimestamp":1765185513,"startTime":"0","endTime":"0","summary":"AB&B BIO-TECH-B (02627) announced the initiation of a Phase III clinical trial for its freeze-dried human rabies vaccine (HDCV). The investigational vaccine targets three immunization regimens. In...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["III","159646","BK1161","02627","BK4134"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2589965335","title":"AB&B Bio-Tech Launches Phase III Trial of Lyophilized Human Rabies Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2589965335","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589965335?lang=en_us&edition=fundamental","pubTime":"2025-12-08 17:09","pubTimestamp":1765184993,"startTime":"0","endTime":"0","summary":"AB&B Bio-Tech Co. Ltd. JS has announced the commencement of Phase III clinical trials for its Lyophilized Human Rabies Vaccine . The vaccine candidate is being developed under three immunization regimens, and the company previously received Investigational New Drug approval for the Essen  regimen in November 2022, as well as approval for the Zagreb  and a simplified four-dose regimen in April 2023. A Phase I clinical trial of the vaccine candidate was completed in October 2024 and demonstrated a promising safety profile. The results of the Phase III clinical trial have not yet been presented and will be available in the future.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AB&B Bio-Tech Co. Ltd. JS published the original content used ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nNDLbkxVxQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02627","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168334587","title":"Ab&B Bio-Tech (2627) Releases Proxy Form for Second EGM in December 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1168334587","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168334587?lang=en_us&edition=fundamental","pubTime":"2025-12-04 22:44","pubTimestamp":1764859465,"startTime":"0","endTime":"0","summary":"Ab&B Bio-Tech (2627) has issued a proxy form for its second extraordinary general meeting of 2025, scheduled for December 23, 2025, at 10 a.m. in Taizhou, Jiangsu, PRC. According to the announcement,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02627"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164243150","title":"AB&B BIO-TECH-B (02627) Nominates Li Jianjun as Independent Non-Executive Director Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=1164243150","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164243150?lang=en_us&edition=fundamental","pubTime":"2025-12-04 22:26","pubTimestamp":1764858371,"startTime":"0","endTime":"0","summary":"AB&B BIO-TECH-B (02627) announced that Ms. Li Xiaoqing has resigned from her positions as independent non-executive director, chairman of the board audit committee, member of the board remuneration...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02627"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2588880281","title":"AB&B Bio-Tech Co. Ltd. JS Announces Date for Second Extraordinary General Meeting of 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2588880281","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588880281?lang=en_us&edition=fundamental","pubTime":"2025-12-04 22:24","pubTimestamp":1764858281,"startTime":"0","endTime":"0","summary":"AB&B Bio-Tech Co. Ltd. JS has announced that its second extraordinary general meeting of 2025 will be held in Taizhou, Jiangsu, PRC on December 23, 2025. During the meeting, shareholders will consider and vote on the appointment of Mr. LI Jianjun as an independent non-executive director of the company and the re-appointment of Deloitte Touche Tohmatsu as the auditors for the year 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AB&B Bio-Tech Co. Ltd. JS published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on December 04, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251204:nNDLH26yh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02627"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106159143","title":"Ab&B Bio-Tech (2627) Announces Independent Director Resignation and Nominates Successor","url":"https://stock-news.laohu8.com/highlight/detail?id=1106159143","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106159143?lang=en_us&edition=fundamental","pubTime":"2025-12-04 22:24","pubTimestamp":1764858255,"startTime":"0","endTime":"0","summary":"Ab&B Bio-Tech CO., LTD. JS (Stock Code: 2627) has announced the resignation of Independent Non-Executive Director Ms. Li Xiaoqing. She will also step down as chairperson of the Audit Committee and as...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02627"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2588880570","title":"AB&B Bio-Tech Co. Ltd. JS Appoints New Independent Director and Reshuffles Board Committees","url":"https://stock-news.laohu8.com/highlight/detail?id=2588880570","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588880570?lang=en_us&edition=fundamental","pubTime":"2025-12-04 22:17","pubTimestamp":1764857824,"startTime":"0","endTime":"0","summary":"AB&B Bio-Tech Co. Ltd. JS has announced the resignation of Ms. Li Xiaoqing as an independent non-executive director, chairperson of the Audit Committee, and member of the Remuneration and Appraisal Committee and Nomination Committee. Mr. Li has been nominated as her replacement and will assume the roles of independent non-executive director, chairperson of the Audit Committee, and member of the Remuneration and Appraisal Committee, pending approval at the upcoming general meeting. Additionally, Mr. Yu Jianlin will step down from the Nomination Committee, while Ms. Li Runxiang and Mr. Chen Chengbei will join the committee.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AB&B Bio-Tech Co. Ltd. JS published the original content used to gen","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251204:nNDL5x1hN0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02627"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148925664","title":"Breakthrough! AB&B BIO-TECH-B's Quadrivalent Influenza Subunit Vaccine \"HuiErKangXin\" Exported to Macau for the First Time","url":"https://stock-news.laohu8.com/highlight/detail?id=1148925664","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148925664?lang=en_us&edition=fundamental","pubTime":"2025-12-04 12:00","pubTimestamp":1764820826,"startTime":"0","endTime":"0","summary":"A crucial step in internationalization strategy has been achieved. Recently, AB&B BIO-TECH-B (02627) successfully delivered its self-developed quadrivalent influenza subunit vaccine, \"HuiErKangXin,\"...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02627","159646","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134728285","title":"10th Zhitong Capital Market Annual Conference Honors Excellence with 25 Awards Unveiled","url":"https://stock-news.laohu8.com/highlight/detail?id=1134728285","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134728285?lang=en_us&edition=fundamental","pubTime":"2025-12-03 19:38","pubTimestamp":1764761917,"startTime":"0","endTime":"0","summary":"On December 3, 2025, the \"10th Zhitong Capital Market Annual Conference & Listed Companies Awards Ceremony,\" jointly hosted by leading Hong Kong and U.S. stock information platform Zhitong Finance...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B8HQ1Z84.USD","BK1207","LU2097828805.USD","LU0823414551.USD","LU0359201612.USD","LU1770034418.SGD","LU0417516571.SGD","HK0000165453.HKD","SGXZ90724238.SGD","BK1132","06160","02469","BK1191","BK1577","BK1605","LU1497733631.SGD","IE00BQXX3F31.USD","02511","BK1148","81211","BK1212","LU0737861699.HKD","LU1303224171.USD","BK1586","LU0831093199.SGD","SG9999004311.SGD","LU0762540952.USD","00960","IE00B29SXG58.USD","LU0823039010.USD","LU1039395188.USD","01519","LU2125910500.SGD","02616","LU0456846285.SGD","00992","BK1553","00867","02392","06060","06090","LU0871576103.HKD","LU0348767384.USD","SG9999015986.USD","BK1504","BK1225","09880","BK1613","03939","02419","BK1167","BK1194","LU0251144936.SGD","LU2177674079.SGD","BK1170","HK0000306685.HKD","BK1521","06963","00382","LU0315179316.USD","BK1518","BK1582","BK1615","LU0274383008.USD","LU0541501648.USD","LU0819123356.HKD","LU0880133367.SGD","01640","02190","BK1229","BK1509","BK1571","06657","02431","IE00BGHQDM52.EUR","BK1574","LU2449936058.SGD","LU0505663152.USD","LU2153592121.USD","06862","IE0008368742.USD","LU1770036033.HKD","LU0067412154.USD","02100","BK1515","LU0348784397.USD","06138","LU1969619763.USD","01164","BK1197","LU0572944931.SGD","LU0979878070.USD","LU0417516738.SGD","BK1560","LU1720050803.USD","BK1596","LU1226288253.USD","BK1554","IE0003851619.USD","LU0455707207.USD","LU0588546209.SGD","LU1794554557.SGD","BK1155","LU0039217434.USD","02567","BK1193","BK1595","SG9999001903.USD","IE00BQXX3C00.GBP","06633","LU2663582299.SGD","LU3063872942.SGD","09878","BK1111","LU1880383440.USD","LU0702159699.USD","LU1831875114.USD","LU0164865239.USD","02598","LU0708995583.HKD","LU0264606111.USD","LU0048575426.USD","02256","02155","LU2023250504.SGD","03658","02020","LU0620787316.HKD","03709","LU0259732245.USD","00136","LU0370786039.SGD","IE00BD6J9T35.USD","LU0561508036.HKD","01762","06988","06996","BK1608","00302","LU0588545490.SGD","00875","LU0594300179.USD","LU0048580855.USD","HYDD.SI","LU1102505929.USD","00267","BK1556","SG9999001226.SGD","IE00B543WZ88.USD","LU0326950275.SGD","LU2460026573.USD","02420","LU0251143458.SGD","LU2424517915.HKD","BK1143","LU2242644610.SGD","LU0228659784.USD","BK1222","02057","09890","BK1230","LU1188198961.HKD","BK1598","IE00B0169L03.USD","LU1242518857.USD","BK1597","02171","LU0640798160.USD","SG9999015978.USD","LU0828238088.HKD","06613","LU1366334578.USD","BK1610","LU2153591404.USD","IE00BZ08YR35.GBP","LU0823426308.USD","BK1100","LU0823397285.USD","BK1227","LU1868837565.USD","00384","BK1237","BK1593","LU0261947096.USD","BK1095","BK1127","BK1240","LU2097828714.EUR","03145","BK1186","LU0051755006.USD","LU0823397103.USD","BK1160","LU1960683339.HKD","LU1242518931.SGD","00305","02436","LU1328277881.USD","LU2357125470.USD","00666","SGXZ86797644.SGD","BK1216","LU1251922891.USD","BK1163","LU1868838027.USD","82331","BK1519","09639","BK1542","LU0819121731.USD","LU0143863784.USD","01833","06855","LU1868837722.USD","BK1557","01333","LU0449515922.USD","BK1555","BK1219","BK1607","01177","LU0488056044.USD","BK1564","00826","02590","LU0072913022.USD","LU0054237671.USD","BK1128","00656","LU0244354667.USD","01651","03836","LU0828237510.HKD","03998","LU0345775950.USD","LU0149721374.USD","LU1048588211.SGD","LU0254981946.USD","02498","IE00BZ08YS42.EUR","LU1226287529.USD","SG9999002950.SGD","BK1541","LU0314109678.HKD","02595","SG9999015945.SGD","LU1046422090.SGD","LU0173614495.USD","02460","BK1502","00017","BK1136","LU2476274308.USD","BK1189","HK0000320264.USD","02331","LU0516423174.USD","LU1282649067.USD","SG9999004220.SGD","LU0540923850.HKD","BK1604","BK1587","LU0052750758.USD","LU0502904849.HKD","LU0611395673.USD","06608","01117","LU1522347837.USD","IE0009570106.USD","01880","02273","BK1228","LU0348766576.USD","01448","09923","LU0531970944.HKD","BK1619","HK0000252152.HKD","01119","BK1131","LU0175139822.USD","LU0634319403.HKD","06186","09956","06168","02382","LU0516422952.EUR","LU0431992006.USD","BK1618","LU0049112450.USD","02096","LU1023057109.AUD","02629","LU2045819591.USD","02889","06919","02315","IE0032431581.USD","LU0287142896.SGD","BK1516","02551","03396","01471","IE00B031HY20.USD","06100","06609","LU0543330566.HKD","LU2039709279.SGD","LU1861214812.USD","BK1566","BK1164","02886","09926","HK0000306701.USD","BK1559","LU0348805143.USD","BK1198","LU1008478684.HKD","LU1366334651.USD","LU1328615791.USD","IE0008369823.USD","LU0289960550.SGD","LNNGY","LU1166156734.SGD","06677","09699","09860","BK1606","BK1151","06821","02142","03680","LU1102505762.USD","LU2249611893.SGD","LU0164872284.USD","BK1126","LU0289739343.SGD","LU0516423091.SGD","LU1152091168.USD","BK1144","BK1137","06086","LU0329678337.USD","BK1168","LU2778985437.USD","SG9999000418.SGD","BK1195","03650","02228","ANPDY","BK1220","09678","86618","LNVGY","09927","02670","BK1239","BK1142","BK1147","IE0034224299.USD","02587","LU0048597586.USD","LU0588545904.SGD","LU0456827905.SGD","SG9999015952.SGD","BK1183","09877","LU2506951792.HKD","09959","02121","00512","00135","BK1258","LU1807302812.USD","LU0499858602.USD","LU1282649810.SGD","02157","LU0417516902.SGD","LU2543165471.USD","01276","BK1139","LU0052756011.USD","LU1226287875.USD","03681","IE00BYV24P56.USD","BK1161","LU0572940350.SGD","01939","00699","LU1974910355.USD","LU0164880469.USD","LU0791590937.USD","02018","LU2488822045.USD","02167","IE00B5MMRT66.SGD","BK1117","03800","LU0231483743.USD","LU0211977185.USD","LU0310800965.SGD","SG9999001069.SGD","LU1917777945.USD","02451","BK1588","BK1594","02177","BK1114","00363","IE00BVYPNP33.GBP","SG9999002828.SGD","LU0516422366.SGD","03677","IE00BZ08YT58.USD","LU0593848301.USD","01877","LU0072462343.USD","LU2238339852.HKD","BK1188","LU0327786744.USD","LU0107464264.USD","LU0384037296.USD","02158","LU1224709979.USD","LU0359201885.HKD","09660","LU2348774022.SGD","BK1224","LU2298064838.USD","01818","01969","LU0823038988.USD","LU0737861772.HKD","02627","02279","LU0348783233.USD","02533","01384","BK1523","LU1152091754.HKD","LU0320764599.SGD","HK0000320223.HKD","IE00BVYPNQ40.USD","IE00B0JY6N72.USD","01440","BK1214","IE00B8L5B284.USD","LU0054450605.USD","BK1175","BK1524","LU0165289439.USD","03738","02509","LU0511384066.AUD","LU1880383366.USD","LU2097828474.EUR","02150","BK1552","IE00B031J352.USD","LU0359202008.SGD","LU2360107325.USD","00003","SG9999000459.SGD","LU1961090484.USD","LU0261950470.USD","LU1235295612.USD","BK1179","LU0082770016.USD","02488","BK1590","00451","BK1209","BK1540","00777","LU0823437842.USD","02858","LU0594300419.USD","01911","LU2328871848.SGD","LU0348735423.USD","02298","01070","01585","82020","BK1526","02400","BK1257","BK1600","02105","BK1171","00798","BK1549","LU0214875030.USD","00884","09985","IE00BMCWC346.EUR","02650","LU0449509016.USD","09636","LU0541502299.USD","09911","LU2506952253.HKD","02013","LU1813983027.USD","09919","01378","SG9999006514.SGD","01405","BK1124","BK1154","BK1215","LU0289961442.SGD","BK1585","SG9999001051.SGD","SGXZ62798434.SGD","IE00BGV7N243.SGD","BK1548","LU1226288170.HKD","LU1861219969.SGD","LU0307460666.USD","01600","BK1235","09990","LU1951186391.HKD","BK1200","06683","SG9999006597.SGD","LU0128525689.USD","LU0143863198.USD","01530","00855","SG9999001093.SGD","LU0164939612.USD","80992","02250","BK1233","BK1512","02506","02268","01773","IE00BQXX3D17.EUR","BK1221","BK1104","LU0650527681.SGD","BK1578","LU1993786604.SGD","LU2399975544.HKD","BK1109","02556","LU0229945570.USD","LU0605514214.HKD","LU1497733557.USD","SG9999000475.SGD","LU1226287792.SGD","LU2097828557.USD","BK1184","LU1497734951.SGD","01735","01318","LU1719994722.HKD","BK1592","LU1981816686.USD","LU1675838814.USD","LU0315178854.USD","BK1247","BK1110","SG9999014674.SGD","06913","BK1579","LU1939255532.USD","LU0823414478.USD","LU1211504680.USD","02525","02565","LU0084288322.USD","BK1530","00020","SG9999003461.SGD","01952","LU0269904917.USD","LU0501845795.SGD","09961","BK1140","LU0856984785.SGD","BK1116","LU0348827113.USD","LU1267930227.SGD","LU2294711713.HKD","BK1527","BK1178","03896","LU1956131251.USD","09690","LU2008162690.USD","BK1544","LU0572939691.SGD","BK1253","02380","01211","LU1481107354.HKD","IE0003795394.USD","LU1115378108.SGD","06618","BK1125","LU2106854487.HKD","09992","BK1583","BK1119","BK1141","02453","LU2097828631.EUR","09955","BK1134","00999","LU1508157978.USD","01907","LU0329678170.USD","00300","BK1500","LU0261950983.USD","BK1520","BK1190","01783","LU0588545730.USD","LU0011963245.USD","01458","BK1096","LU2348773727.SGD","01520","02411","06069","BYDDY","BK1589","IE0031814852.USD","LU0348825331.USD","LU0516422440.USD","02276","01739","LU1808992512.USD","02696","BK1528","02197","HK0000252160.HKD","01809","LU0823426480.USD","SG9999011746.SGD","00460","LU0865486749.SGD","80020","BK1531","02552","BK1550","LU0043850808.USD","LU0082770016.SGD","01681","LU0469268626.HKD","BK1616","LU0531971595.HKD","LU0345776255.USD","06058","00861","LU0140636845.USD","LU0509642566.USD","LU0463099449.HKD","LU0499858438.USD","SG9999002562.SGD","BK1169","IE00BPRC5H50.USD","BK1591","09996","BK1150","LU0791591158.USD","002594","LU1634259391.SGD","BK1539","LU1634259557.SGD","BK1617","BK1575","BK1609","LU2476274720.SGD","LU0868486357.SGD","BK1158","BK1522","01093","02145","SG9999002463.SGD","HK0000500386.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1141910902","title":"Ab&B Bio-Tech Co., Ltd. JS (02627) Provides Monthly Return for November 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1141910902","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141910902?lang=en_us&edition=fundamental","pubTime":"2025-12-01 17:05","pubTimestamp":1764579937,"startTime":"0","endTime":"0","summary":"Ab&B Bio-Tech Co., Ltd. JS (stock code: 02627) released its monthly return for November 2025, confirming no changes in authorized or issued share capital during the reporting period. The total...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02627"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117424956","title":"Riding the Hong Kong Stock Rally: Bull Market Dawns in the East 2026 – 10th Zhitong Finance Capital Markets Annual Conference Invites You to a Capital Feast","url":"https://stock-news.laohu8.com/highlight/detail?id=1117424956","media":"Stock News","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117424956?lang=en_us&edition=fundamental","pubTime":"2025-11-18 08:56","pubTimestamp":1763427395,"startTime":"0","endTime":"0","summary":"As the fourth technological revolution sweeps across the globe, with AI and large model technologies reaching critical breakthroughs, capital engines are driving the revaluation of Chinese assets at...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1542","09860","09919","01228","BK1539","BK1186","01681","BK1207","06682","BK1258","00302","00826","HK0000252160.HKD","BK1585","BK1202","BK1178","01333","09678","00363","BK1114","BK1594","IE00B543WZ88.USD","03658","01164","LU2460026573.USD","BK1579","BK1124","LU2476274720.SGD","06100","06919","01907","HK0000252152.HKD","SG9999001069.SGD","SG9999004220.SGD","LU2476274308.USD","06633","BK1132","03738","BK1556","06090","HK0000500386.USD","SG9999015945.SGD","SG9999015978.USD","BK1506","00604","BK1150","BK1575","BK1582","09911","BK1140","BK1155","LU0348825331.USD","BK1618","01167","02858","00290","IE00BGHQDM52.EUR","SG9999003461.SGD","02453","IE00BVYPNQ40.USD","BK1141","02627","06660","02551","BK1225","BK1110","BK1191","BK1578","02142","SG9999002950.SGD","BK1591","02670","BK1592","09878","BK1531","06608","BK1193","BK1596","BK1221","BK1516","BK1613","BK1586","02380","00867","BK1131","00003","BK1609","BK1527","BK1619","BK1175","09959","BK1229","00196","BK1583","02096","BK1109","BK1577","01809","BK1500","LU1497734951.SGD","03315","02886","LU2778985437.USD","BK1606","IE00B5MMRT66.SGD","00855","06609","BK1171","02177","01651","02268","00861","BK1095","02488","02533","BK1116","02587","06677","BK1518","LU1497733557.USD","02431","BK1555","02511","LU2488822045.USD","BK1188","02171","02420","01318","02616","BK1521","LU1634259391.SGD","BK1147","06996","00305","02256","BK1161","BK1219","IE00BMCWC346.EUR","02105","00552","BK1137","BK1148","BK1230","BK1104","BK1224","BK1100","LU0417516902.SGD","00382","02157","BK1142","SG9999015986.USD","BK1209","BK1216","BK1552","BK1125","BK1194","01762","LU0348767384.USD","BK1587","BK1595","IE00BPRC5H50.USD","06069","SG9999015952.SGD","09996","02279","BK1163","BK1608","BK1574","SG9999014674.SGD","02411","02567","01783","BK1139","BK1183","LU1634259557.SGD","01773","BK1524","02167","02561","03145","BK1530","LU1522347837.USD","00699","IE00BYV24P56.USD","BK1593","LU1808992512.USD","02509","LU0348766576.USD","IE00BVYPNP33.GBP","BK1144","01969","BK1529","BK1228","LU1497733631.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178407621","title":"Ab&B Bio-Tech (2627) Announces Commencement of Phase I Clinical Trials for Influenza Vaccines","url":"https://stock-news.laohu8.com/highlight/detail?id=1178407621","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178407621?lang=en_us&edition=fundamental","pubTime":"2025-11-13 16:42","pubTimestamp":1763023341,"startTime":"0","endTime":"0","summary":"Ab&B Bio-Tech CO., LTD. JS (2627) has initiated Phase I clinical trials of its adjuvanted quadrivalent subunit influenza vaccine and adjuvanted trivalent subunit influenza vaccine. According to the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02627"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119410585","title":"AB&B BIO-TECH-B (02627) Initiates Phase I Clinical Trials for Quadrivalent and Trivalent Influenza Subunit Vaccines (Adjuvanted)","url":"https://stock-news.laohu8.com/highlight/detail?id=1119410585","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119410585?lang=en_us&edition=fundamental","pubTime":"2025-11-13 16:42","pubTimestamp":1763023335,"startTime":"0","endTime":"0","summary":"AB&B BIO-TECH-B (02627) announced the initiation of Phase I clinical trials for its quadrivalent influenza virus subunit vaccine (adjuvanted) and trivalent influenza virus subunit vaccine...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159646","02627","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2583554708","title":"AB&B Bio-Tech Launches Phase I Trial for Adjuvanted Influenza Vaccines","url":"https://stock-news.laohu8.com/highlight/detail?id=2583554708","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583554708?lang=en_us&edition=fundamental","pubTime":"2025-11-13 16:33","pubTimestamp":1763022798,"startTime":"0","endTime":"0","summary":"AB&B Bio-Tech Co. Ltd. JS has announced the commencement of Phase I clinical trials for its adjuvanted quadrivalent subunit influenza vaccine and adjuvanted trivalent subunit influenza vaccine. The company recently received Investigational New Drug approvals from the National Medical Products Administration of the People's Republic of China for these vaccine candidates. No results from these clinical trials have been presented yet.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AB&B Bio-Tech Co. Ltd. JS published the original content used to generate this news brief on November 13, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nNDLQ1Rjz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02627"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":63,"code":"91000000","status":"200"}]}}